Published in J Med Microbiol on June 01, 1996
Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol (1999) 5.88
Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol (1997) 3.57
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol (2000) 3.23
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol (2000) 3.21
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol (2004) 3.20
Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol (2002) 2.25
Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother (2012) 1.97
Comparison of different PCR approaches for typing of Francisella tularensis strains. J Clin Microbiol (2000) 1.80
Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol (2007) 1.52
Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J Clin Microbiol (2009) 1.39
Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol (1999) 1.32
Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (1997) 1.32
Higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals in Beijing. PLoS One (2013) 1.20
Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol (2010) 1.12
Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J Antimicrob Chemother (2011) 1.06
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother (2010) 1.01
Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J Clin Microbiol (2004) 1.00
Genetic variability among ampC genes from acinetobacter genomic species 3. Antimicrob Agents Chemother (2008) 0.97
Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain. Eur J Clin Microbiol Infect Dis (1998) 0.96
Dynamics and diversity of Escherichia coli in animals and system management of the manure on a commercial farrow-to-finish pig farm. Appl Environ Microbiol (2012) 0.92
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel. Eur J Clin Microbiol Infect Dis (2012) 0.90
Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol (2002) 0.90
Acinetobacter calcoaceticus from a fatal case of pneumonia harboring bla(NDM-1) on a widely distributed plasmid. BMC Infect Dis (2015) 0.86
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru. Trans R Soc Trop Med Hyg (2013) 0.84
Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study. BMC Infect Dis (2013) 0.83
Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks. J Clin Microbiol (2015) 0.83
Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center. PLoS One (2016) 0.83
Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system. Front Microbiol (2015) 0.82
Acquisition of a pathogenicity island in an Escherichia coli clinical isolate causing febrile urinary tract infection. Eur J Clin Microbiol Infect Dis (2011) 0.78
Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control (2017) 0.76
Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil. Mem Inst Oswaldo Cruz (2015) 0.75
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med (1999) 2.55
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med (1996) 2.22
Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J (1998) 2.13
Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy. AIDS (2001) 1.92
Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature (1993) 1.82
Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains. J Clin Microbiol (1989) 1.76
New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet (2001) 1.70
Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax (2009) 1.56
Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med (2000) 1.51
Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Clin Infect Dis (2003) 1.39
Etiology of traveller's diarrhea in Spanish travellers to developing countries. Eur J Epidemiol (1993) 1.38
Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis (1988) 1.31
Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J (2006) 1.29
Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J (2000) 1.28
Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood (1998) 1.28
Rapid detection of gastric Campylobacter pylori colonization by a simple biochemical test. J Clin Microbiol (1989) 1.23
Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii. J Med Microbiol (1995) 1.17
Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med (2000) 1.16
Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother (2006) 1.14
Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic. Eur Respir J (2010) 1.12
C-reactive protein levels in community-acquired pneumonia. Eur Respir J (2003) 1.11
Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis (1998) 1.11
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J (2011) 1.11
Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax (2010) 1.10
Interleukin-2-dependent autocrine proliferation in T-cell development. Nature (1989) 1.09
Human T-cell precursors: involvement of the IL-2 pathway in the generation of mature T cells. Immunol Rev (1988) 1.09
Murine acariasis. II. Immunological dysfunction and evidence for chronic activation of Th-2 lymphocytes. Scand J Immunol (1996) 1.05
Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice. J Exp Med (1991) 1.04
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone. Eur J Clin Microbiol Infect Dis (2005) 1.01
The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J Antimicrob Chemother (1997) 1.00
A case-control study of diarrhoea in children caused by Escherichia coli producing heat-stable enterotoxin (EAST-1). J Med Microbiol (1998) 1.00
Markers of treatment failure in hospitalised community acquired pneumonia. Thorax (2008) 1.00
Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors. J Exp Med (1988) 0.99
Diagnostic value of telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia using the Metras catheter. Am Rev Respir Dis (1988) 0.98
Systemic candidiasis in Spanish heroin addicts: a possible source of infection. J Infect Dis (1987) 0.96
Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant (1997) 0.96
Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. J Immunol (1999) 0.95
Ontogenic characterization of thymic B lymphocytes. Analysis in different mouse strains. Eur J Immunol (1990) 0.94
Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development. Lancet (1988) 0.94
A role for T3+4-6-8- transitional thymocytes in the differentiation of mature and functional T cells from human prothymocytes. Proc Natl Acad Sci U S A (1986) 0.94
Determination of D-lactate concentration for rapid diagnosis of bacterial infections of body fluids. Eur J Clin Microbiol Infect Dis (1991) 0.93
Alpha/beta heterodimeric T-cell receptor expression early in thymocyte differentiation. J Mol Cell Immunol (1988) 0.93
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J (2008) 0.92
Differentiation of human mature thymocytes: existence of a T3+4-8- intermediate stage. Eur J Immunol (1986) 0.92
Epidemiological markers of Acinetobacter baumannii clinical isolates from a spinal cord injury unit. J Hosp Infect (1994) 0.90
Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transpl Infect Dis (2007) 0.90
Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR). Ophthalmic Res (2000) 0.88
Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1. Eur Respir J (2011) 0.88
Comparative study of virulence traits of Escherichia coli clinical isolates causing early and late neonatal sepsis. J Clin Microbiol (2007) 0.88
Observations on the mode of action of normal immunoglobulin at high doses. Immunol Rev (1994) 0.87
Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol (1995) 0.87
Development of Ly-1+ B cells in immunodeficient CBA/N mice. J Exp Med (1987) 0.86
Interleukin 2 pathway is autonomously activated in human T11+3-4-6-8- thymocytes. Eur J Immunol (1987) 0.86
Influenza A H1N1 in HIV-infected adults. HIV Med (2011) 0.85
A functional idiotypic network of T helper cells and antibodies, limited to the compartment of "naturally" activated lymphocytes in normal mice. Eur J Immunol (1987) 0.85
All VH11 genes expressed in peritoneal lymphocytes encode anti-bromelain-treated mouse red blood cell autoantibodies but other VH gene families contribute to this specificity. Eur J Immunol (1990) 0.85
Isolation and characterization of (gamma, delta) CD4+ T cell clones derived from human fetal liver cells. J Exp Med (1989) 0.85
Expression of alkaline phosphatase in murine B lymphocytes. Correlation with B cell differentiation into Ig secretion. J Immunol (1989) 0.85
Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea. J Clin Microbiol (1997) 0.85
Epidemiology of pneumonia in kidney transplantation. Transplant Proc (2010) 0.85
Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis (1988) 0.85
Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients. Transplant Proc (2007) 0.84
No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J Neurol (2001) 0.83
Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas. J Med Virol (2008) 0.83
Influence of cytomegalovirus disease in outcome of solid organ transplant patients. Transplant Proc (2011) 0.83
Identification of Salmonella spp. with Rambach agar in conjunction with the 4-methylumbelliferyl caprylate (MUCAP) fluorescence test. Br J Biomed Sci (1994) 0.82
Mutual cell interactions and the selection of immune repertoires: implication in autoimmunity. Immunol Today (1989) 0.82
Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin. Antimicrob Agents Chemother (1984) 0.82
Rapid detection of urinary tract infection caused by Escherichia coli or Proteeae species. Eur J Clin Microbiol Infect Dis (1991) 0.82
The participation of B cells and antibodies in the selection and maintenance of T cell repertoires. Immunol Rev (1988) 0.82
Functional double-negative T cells in the periphery express T cell receptor V beta gene products that cause deletion of single-positive T cells. Eur J Immunol (1993) 0.82
Studies on the T cell dependence of natural IgM and IgG antibody repertoires in adult mice. Eur J Immunol (1995) 0.81
Long-lived polyclonal B-cell lines derived from midgestation mouse embryo lymphohematopoietic progenitors reconstitute adult immunodeficient mice. Blood (2001) 0.81
Virological diagnosis in community-acquired pneumonia in immunocompromised patients. Eur Respir J (2007) 0.81
Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ (1999) 0.81
Inside the thymus, Mls antigen is exclusively presented by B lymphocytes. Res Immunol (1990) 0.81
Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum. J Med Virol (1999) 0.81
Diagnosis of Entamoeba histolytica and Entamoeba dispar in clinical specimens by PCR-SHELA. Arch Med Res (1997) 0.80
Aetiology of traveller's diarrhoea: evaluation of a multiplex PCR tool to detect different enteropathogens. Clin Microbiol Infect (2014) 0.80
Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation. Transplant Proc (2009) 0.80
Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-V beta 8 antibodies. Eur J Immunol (1992) 0.80
Opportunistic pulmonary infections in solid organ transplant recipients. Transplant Proc (2012) 0.80
Comparison of rufloxacin and norfloxacin effects on faecal flora. J Antimicrob Chemother (1995) 0.80
Initiation of hemopoiesis in the mouse embryo. Ann N Y Acad Sci (1994) 0.80
V-region connectivity in T cell repertoires. Annu Rev Immunol (1989) 0.80
Presence of an autoantibody against a Golgi cisternal membrane protein in the serum and cerebrospinal fluid from a patient with idiopathic late onset cerebellar ataxia. J Neuroimmunol (1988) 0.80
Functional and biochemical evidence for the recognition of T cell receptors by monoclonal antibodies to an immunoglobulin idiotype. J Mol Cell Immunol (1986) 0.80
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. AIDS (2000) 0.78
Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol (1992) 0.78
Outbreak of norovirus gastroenteritis among staff at a hospital in Barcelona, Spain, September 2007. Euro Surveill (2007) 0.77
lpr T cells vaccinate against lupus in MRL/lpr mice. Eur J Immunol (1992) 0.77
Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin. Antimicrob Agents Chemother (1983) 0.77
Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin. Nephron (1985) 0.77
Some reasons why deletion and anergy do not satisfactorily account for natural tolerance. Res Immunol (1992) 0.77
Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance? Med Clin North Am (2001) 0.76
D-lactic acid in synovial fluid. A rapid diagnostic test for bacterial synovitis. J Rheumatol (1995) 0.76
Insights into autoimmunity: from classical models to current perspectives. Immunol Rev (1990) 0.76